RCUS financials
Arcus Biosciences (RCUS) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
RCUS income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $247.00M | $237.00M | -$386.00M | -$353.00M | -3.29 |
| 2024 | $258.00M | $258.00M | -$330.00M | -$283.00M | -3.14 |
| 2023 | $117.00M | $117.00M | -$340.00M | -$307.00M | -4.15 |
| 2022 | $112.00M | $112.00M | -$280.00M | -$267.00M | -3.71 |
| 2021 | $383.00M | $383.00M | $54.00M | $53.00M | 0.71 |
| 2020 | $78.00M | $78.00M | -$124.00M | -$123.00M | -2.24 |
- RCUS revenue was $247.00M in fiscal 2025, net income -$353.00M.
Updated 2026-11-03 12:35 UTC